Pastorio C, Noettger S, Nchioua R, Zech F, Sparrer K, Kirchhoff F. Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization. iScience. 2023;26:108299 pubmed publisher

Saunders N, Fernandez I, Planchais C, Michel V, Rajah M, Baquero Salazar E, et al. TMPRSS2 is a functional receptor for human coronavirus HKU1. Nature. 2023;624:207-214 pubmed publisher

Garc xed a Murria M, Gadea Salom L, Moreno S, Rius Salvador M, Zaragoza O, Brun A, et al. Identification of small molecules capable of enhancing viral membrane fusion. Virol J. 2023;20:99 pubmed publisher

Wettstein L, Immenschuh P, Weil T, Conzelmann C, Almeida Hern xe1 ndez Y, Hoffmann M, et al. Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection. J Med Virol. 2023;95:e28124 pubmed publisher

Harte J, Wakerlin S, Lindsay A, McCarthy J, Coleman Vaughan C. Metalloprotease-Dependent S2'-Activation Promotes Cell-Cell Fusion and Syncytiation of SARS-CoV-2. Viruses. 2022;14: pubmed publisher

Fuchs E, Rudnik Jansen I, Dinesen A, Selnihhin D, Mandrup O, Thiam K, et al. An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension. Acta Biomater. 2022;153:411-418 pubmed publisher

Su P, Zhai D, Wong A, Liu F. Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice. Mol Brain. 2022;15:71 pubmed publisher

Roelle S, Shukla N, Pham A, Bruchez A, Matreyek K. Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains. PLoS Biol. 2022;20:e3001738 pubmed publisher

Wettstein L, Knaff P, Kersten C, Muller P, Weil T, Conzelmann C, et al. Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture. Commun Biol. 2022;5:681 pubmed publisher

Tortorici M, Walls A, Joshi A, Park Y, Eguia R, Miranda M, et al. Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein. Cell. 2022;185:2279-2291.e17 pubmed publisher

Fraser B, Beldar S, Seitova A, Hutchinson A, Mannar D, Li Y, et al. Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation. Nat Chem Biol. 2022;: pubmed publisher

Mahalingam G, Rachamalla H, Arjunan P, Periyasami Y, M S, Thangavel S, et al. Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System. Front Pharmacol. 2022;13:840727 pubmed publisher

Lee S, Kim D, Jung Y. Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation. Virus Genes. 2022;58:172-179 pubmed publisher

David A, Parkinson N, Peacock T, Pairo Castineira E, Khanna T, Cobat A, et al. A common TMPRSS2 variant has a protective effect against severe COVID-19. Curr Res Transl Med. 2022;70:103333 pubmed publisher

Balachandran H, Phetsouphanh C, Agapiou D, Adhikari A, Rodrigo C, Hammoud M, et al. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses. Cell Rep. 2022;38:110345 pubmed publisher

Valero J, Civit L, Dupont D, Selnihhin D, Reinert L, Idorn M, et al. A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher

Liu X, Luongo C, Matsuoka Y, Park H, Santos C, Yang L, et al. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher

Ashhurst A, Tang A, Fajtová P, Yoon M, Aggarwal A, Bedding M, et al. Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L. J Med Chem. 2021;: pubmed publisher

Cecon E, Burridge M, Cao L, Carter L, Ravichandran R, Dam J, et al. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET. Cell Chem Biol. 2021;: pubmed publisher

Colson A, Depoix C, Dessilly G, Baldin P, Danhaive O, Hubinont C, et al. Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2. Am J Pathol. 2021;191:1610-1623 pubmed publisher

Peacock T, Goldhill D, Zhou J, Baillon L, Frise R, Swann O, et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol. 2021;6:899-909 pubmed publisher

Wettstein L, Weil T, Conzelmann C, Müller J, Groß R, Hirschenberger M, et al. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun. 2021;12:1726 pubmed publisher

Wang R, Simoneau C, Kulsuptrakul J, Bouhaddou M, Travisano K, Hayashi J, et al. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Cell. 2021;184:106-119.e14 pubmed publisher

Dieterle M, Haslwanter D, Bortz R, Wirchnianski A, Lasso G, Vergnolle O, et al. A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. bioRxiv. 2020;: pubmed publisher

Edie S, Zaghloul N, Leitch C, Klinedinst D, Lebron J, Thole J, et al. Survey of Human Chromosome 21 Gene Expression Effects on Early Development in Danio rerio. G3 (Bethesda). 2018;8:2215-2223 pubmed publisher